Мировой рынок реагентов и устройств для иммуноферментного анализа – тенденции отрасли и прогноз до 2031 года

Анализ и размер рынка реагентов и устройств для иммуноферментного анализа

Рынок реагентов и устройств для иммуноферментного анализа представляет собой непрерывную интеграцию передовых технологий, таких как автоматизация и миниатюризация, для повышения эффективности и точности диагностических процессов. Эти инновации оптимизируют рабочий процесс в лабораториях, сокращают время выполнения и повышают точность иммуноферментных тестов. Приверженность отрасли технологическим достижениям улучшает диагностические возможности и способствует растущему внедрению этих реагентов и устройств в различных медицинских учреждениях по всему миру.

Компания Data Bridge Market Research анализирует, что глобальный рынок реагентов и устройств для иммуноферментного анализа, который в 2023 году составил 44 49 219,95 млн долларов США, как ожидается, достигнет 67 76 551,81 млн долларов США к 2031 году при среднегодовом темпе роста 5,4% в прогнозируемый период с 2024 по 2031 год. Помимо информации о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные компанией Data Bridge Market Research, также включают в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативно-правовую базу.

Объем и сегментация рынка иммуноферментных реагентов и устройств

Определение рынка

Рынок реагентов и устройств для иммуноанализа относится к отрасли, которая производит компоненты и инструменты, используемые в методах иммуноанализа для обнаружения и измерения определенных веществ, таких как антитела или антигены, в биологических образцах. Эти реагенты включают антитела, антигены, ферменты и другие биомолекулы, необходимые для процесса иммуноанализа. Ключевые игроки на рынке постоянно внедряют инновации и разрабатывают новые реагенты и устройства, способствуя росту.

Динамика мирового рынка реагентов и устройств для иммуноферментного анализа

Драйверы

• Растущий спрос на диагностику

Рост распространенности инфекционных и хронических заболеваний во всем мире привел к росту спроса на точные и эффективные диагностические инструменты. Реагенты и устройства для иммуноферментного анализа играют решающую роль в диагностике различных состояний, способствуя расширению рынка, поскольку системы здравоохранения сосредотачиваются на раннем выявлении и мониторинге заболеваний.

• Увеличение старения населения  

Растущее старение населения во всем мире является ключевой демографической тенденцией, влияющей на динамику рынка. По мере старения людей растет спрос на медицинские услуги, особенно в области мониторинга и диагностики возрастных заболеваний. Эта тенденция вызвала заметный рост потребности в диагностике на основе иммуноферментного анализа, которая играет решающую роль в выявлении и лечении различных заболеваний, распространенных среди пожилых людей. Технология иммуноферментного анализа, известная своей точностью и чувствительностью, отлично подходит для выявления биомаркеров, связанных с возрастными заболеваниями, способствуя эффективному лечению заболеваний.

Возможности

• Тестирование в месте оказания медицинской помощи

The increasing demand for timely and efficient healthcare solutions, point-of-care testing allows for on-the-spot testing, minimizing the need for centralized laboratories. This trend is driven by the growing prevalence of infectious diseases and chronic conditions, emphasizing the importance of quick and reliable diagnostic results. The immunoassay reagents and devices market is poised to benefit from the adoption of POCT, as it offers healthcare professionals the ability to make informed decisions at the patient's bedside, enhancing patient care and treatment outcomes. This shift towards decentralized testing reflects a key market advantage, addressing the need for accessible and immediate diagnostic solutions on a global scale.

• Biomarker Discovery

Biomarker discovery is a crucial aspect of medical research that involves identifying specific molecules, known as biomarkers, in the body that indicate the presence or progression of a disease. Immunoassay reagents and devices play a vital role in detecting and measuring these biomarkers, aiding in early disease diagnosis and monitoring. The market's growth is driven by the increasing demand for advanced diagnostic tools, rising prevalence of chronic diseases, and the emphasis on personalized medicine. As biomarker discovery continues to advance, the global immunoassay reagents and devices market is positioned for substantial expansion, offering innovative solutions for precise and early disease detection.

Restraints/Challenges

• High Costs

The expenses involved in research, development, and production of immunoassay reagents and devices contribute to elevated costs. This, in turn, hampers market accessibility for both manufacturers and consumers. The intricate nature of immunoassay technology demands sophisticated instrumentation and specialized reagents, further adding to the financial burden. High production costs may limit the affordability of these diagnostic tools, restricting their widespread adoption.

• Regulatory Challenges

The immunoassay industry is subject to rigorous regulatory scrutiny and approval processes. Meeting the stringent standards set by health authorities can be time-consuming and resource-intensive for manufacturers. Delays in regulatory approvals may impede the timely introduction of new products to the market, affecting innovation and competitiveness within the industry.

This global immunoassay reagents and devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global immunoassay reagents and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2022, Getein unveiled the MAGICL 6000 CLIA analyzer at MEDICA 2022, catering to mid to high-workflow laboratories with its compact design. This innovative one-step CLIA solution provides optimal efficiency for such laboratory settings
• In November 2022, LumiraDx launched a rapid microfluidic immunoassay HbA1c test across Europe, parts of the Middle East, Asia, Latin America, and Africa. This expansion signifies a strategic move to make this diagnostic tool widely available in diverse regions
• In April 2022, Bio-Techne Corporation and Cygnus Technologies introduced the Simple Plex HEK 293 HCP 3G assay for automated process impurity detection on the Ella immunoassay platform. Addressing the vital need for impurity clearance in Gene and Cell Therapy applications, this assay facilitates accurate quantification of host cell proteins (HCP) throughout viral production phases, aligning with regulatory criteria for ensuring product purity
• In February 2022, Hycor Biomedical Inc secured additional FDA 510(k) clearance for the NOVEOS Immunoassay Analyzer, a chemiluminescent diagnostic tool designed to measure analyte concentrations in human samples. The device, specializing in allergy diagnosis, enhances the capabilities of in-vitro diagnostic equipment
• In January 2021, Abbott's Panbio COVID-19 Ag Rapid Test Device received the CE Mark for asymptomatic SARS-CoV-2 virus diagnosis. This test, equipped with self-swabbing capabilities, offers an efficient and accessible solution for detecting the virus in diverse settings

Global Immunoassay Reagents and Devices Market Scope

The global immunoassay reagents and devices market is segmented on the basis of product, platform, technique, specimen type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Reagents and Kits
• Analyzers

Platform                                                                                               

• Chemiluminescence Immunoassays
• Fluorescence Immunoassays
• Enzyme Immunoassay
• Radioimmunoassays
• Others

Technique

• Enzyme-Linked Immunosorbent Assays
• Rapid Tests
• Enzyme-Linked Immunospot
• Western Blotting
• Immuno-PCR
• Other Techniques

Specimen Type

• Blood
• Urine
• Saliva
• Others

Application

• Infectious Diseases
• Oncology And Endocrinology
• Bone and Mineral Disorders
• Cardiology
• Hematology and Blood Screening
• Autoimmune Disorders
• Toxicology
• Neonatal Screening
• Other Applications

End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical And Biotechnology Companies
• Blood Banks
• Research and Academic Laboratories
• Others

Global Immunoassay Reagents and Devices Market Regional Analysis/Insights

The global immunoassay reagents and devices market are analysed and market size insights and trends are provided by country, product, platform, technique, specimen type, application and end user as referenced above.

The countries covered in the global immunoassay reagents and devices market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates in the global immunoassay reagents and devices market, both in terms of market share and revenue. This dominance is expected to persist from 2024 to 2031, driven by heightened investments in research and development, growing government initiatives, and enhanced healthcare infrastructure across the region. The increased focus on these factors contributes to the flourishing market presence of North America in the field of immunoassay technologies.

The Asia-Pacific is expected to experience the most rapid growth in the global immunoassay reagents and devices market from 2024 to 2031. This can be attributed to heightened government investments in the healthcare sector and a surge in technological advancements. The region's commitment to healthcare initiatives further propels its position as a key player in driving market expansion during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The global immunoassay reagents and devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global immunoassay reagents and devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global immunoassay reagents and devices market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Immunoassay Reagents and Devices Market Share Analysis

The global immunoassay reagents and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global immunoassay reagents and devices market.

Some of the major players operating in the global immunoassay reagents and devices market are:

• F. Hoffmann-La Roche Ltd (Switzerland)
• Siemens (Germany)
• Randox Laboratories Ltd. (U.K.)
• Abbott (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Merck KGaA (Germany)
• Beckman Coulter, Inc. (U.S.)
• BIOMÉRIEUX (France)
• Thermo Fisher Scientific Inc. (U.S.)
• BD (U.S.)
• Mindray Bio-Medical Electronics Co., Ltd. (China)
• DiaSorin S.p.A (Italy)
• Ortho Clinical Diagnostics (U.S.)
• QIAGEN (Germany)
• QuidelOrtho Corporation (U.S.)
• BioCheck (U.S.)
• Bio-Techne (U.S.)
• PerkinElmer Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• MESO SCALE DIAGNOSTICS, LLC (U.S.)

SKU-1726